The big flaw with the minimal “lives saved” argument, which is essentially suggesting that screening should be very limited, is that there can be a long, hard road between detecting PCa and actually dying from the PCa. So the death count ignores those that require extensive treatments (with significant side effects) due to the PCa remaining undetected until advanced / metastasized.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.